Transcatheter Aortic Valve Replacement and Concomitant Mitral Regurgitation

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2018 Jul 5

PMID 29971238

Citations 8

Authors

Barbara E Stahli

Markus Reinthaler

David M Leistner

Ulf Landmesser

Alexander Lauten

Affiliations

Soon will be listed here.

Abstract

Mitral regurgitation frequently coexists in patients with severe aortic stenosis. Patients with moderate to severe mitral regurgitation at the time of transcatheter aortic valve replacement are at increased risk of future adverse events. Whether concomitant mitral regurgitation is independently associated with worse outcomes after TAVR remains a matter of debate. The optimal therapeutic strategy in these patients-TAVR with evidence-based heart failure therapy, combined TAVR and transcatheter mitral valve intervention, or staged transcatheter therapies-is ill-defined, and guideline-based recommendations in patients at increased risk for open heart surgery are lacking. Hence, a thorough evaluation of the aortic and mitral valve anatomy and function, along with an in-depth assessment of the patients' baseline risk profile, provides the basis for an individualized treatment approach. The aim of this review is therefore to give an overview of the current literature on mitral regurgitation in TAVR, focusing on different diagnostic and therapeutic strategies and optimal clinical decision making.

Citing Articles

Severe Aortic Stenosis Associated with Other Valve Diseases: Open Surgery or Percutaneous Treatment?.

Moral S, Abuli M, Ballesteros E, Vilardell P, Gutierrez L, Brugada R Rev Cardiovasc Med. 2024; 25(3):99.

PMID: 39076950 PMC: 11263836. DOI: 10.31083/j.rcm2503099.

Update on Percutaneous Treatment for HFrEF: A Great Armamentarium for a Poor Ventricular Function.

Sisinni A, Casenghi M, Popolo Rubbio A, Berni A, Bedogni F, Barbato E Rev Cardiovasc Med. 2024; 24(5):128.

PMID: 39076731 PMC: 11273015. DOI: 10.31083/j.rcm2405128.

Transcatheter mitral valve implantation using the Tendyne valve in a patient with prior transcatheter aortic valve implantation: a case report.

Shah M, Almahrous N, Alreshidan M, Alshehri H Eur Heart J Case Rep. 2023; 7(10):ytad476.

PMID: 37860683 PMC: 10583539. DOI: 10.1093/ehjcr/ytad476.

Prognostic relevance of mitral and tricuspid regurgitation after transcatheter aortic valve implantation: Impact of follow-up time point for decision-making.

Baz L, Mobius-Winkler S, Diab M, Kraplin T, Westphal J, Ibrahim K Front Cardiovasc Med. 2023; 10:990373.

PMID: 36873389 PMC: 9977804. DOI: 10.3389/fcvm.2023.990373.

Concomitant mitral regurgitation in patients with low-gradient aortic stenosis: an analysis from the German Aortic Valve Registry.

Alushi B, Ensminger S, Herrmann E, Balaban U, Bauer T, Beckmann A Clin Res Cardiol. 2022; 111(12):1377-1386.

PMID: 35984497 PMC: 9681685. DOI: 10.1007/s00392-022-02067-2.

References

Grayburn P, Carabello B, Hung J, Gillam L, Liang D, Mack M . Defining "severe" secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol. 2014; 64(25):2792-801. DOI: 10.1016/j.jacc.2014.10.016. View

Figulla H, Webb J, Lauten A, Feldman T . The transcatheter valve technology pipeline for treatment of adult valvular heart disease. Eur Heart J. 2016; 37(28):2226-39. DOI: 10.1093/eurheartj/ehw153. View

Lauten A, Figulla H, Mollmann H, Holzhey D, Kotting J, Beckmann A . TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention. 2014; 10(7):850-9. DOI: 10.4244/EIJV10I7A145. View

Sannino A, Losi M, Schiattarella G, Gargiulo G, Perrino C, Stabile E . Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis. Am J Cardiol. 2014; 114(6):875-82. DOI: 10.1016/j.amjcard.2014.06.022. View

Lancellotti P, Tribouilloy C, Hagendorff A, Popescu B, Edvardsen T, Pierard L . Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013; 14(7):611-44. DOI: 10.1093/ehjci/jet105. View

Ruel M, Kapila V, Price J, Kulik A, Burwash I, Mesana T . Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006; 114(1 Suppl):I541-6. DOI: 10.1161/CIRCULATIONAHA.105.000976. View

Delgado V, Kapadia S, Ajmone Marsan N, Schalij M, Tuzcu E, Bax J . Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart. 2011; 97(20):1704-14. DOI: 10.1136/hrt.2011.227785. View

Moazami N, Diodato M, Moon M, Lawton J, Pasque M, Herren R . Does functional mitral regurgitation improve with isolated aortic valve replacement?. J Card Surg. 2004; 19(5):444-8. DOI: 10.1111/j.0886-0440.2004.00362.x. View

Shibayama K, Harada K, Berdejo J, Mihara H, Tanaka J, Gurudevan S . Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014; 7(2):344-51. DOI: 10.1161/CIRCIMAGING.113.000942. View

10.

Nombela-Franco L, Barbosa Ribeiro H, Urena M, Allende R, Amat-Santos I, DeLarochelliere R . Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014; 63(24):2643-58. DOI: 10.1016/j.jacc.2014.02.573. View

11.

Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R . Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013; 112(2):272-9. DOI: 10.1016/j.amjcard.2013.03.024. View

12.

Schubert S, Yarboro L, Madala S, Ayunipudi K, Kron I, Kern J . Natural history of coexistent mitral regurgitation after aortic valve replacement. J Thorac Cardiovasc Surg. 2016; 151(4):1032-9, 1042.e1. DOI: 10.1016/j.jtcvs.2015.12.006. View

13.

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

14.

Katte F, Franz M, Jung C, Figulla H, Leistner D, Jakob P . Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis. EuroIntervention. 2017; 13(14):1635-1644. DOI: 10.4244/EIJ-D-17-00476. View

15.

Rodes-Cabau J . Transcatheter Mitral Valve Replacement: First Steps on a Long Road. J Am Coll Cardiol. 2018; 71(1):22-24. DOI: 10.1016/j.jacc.2017.11.015. View

16.

Siminiak T, Wu J, Haude M, Hoppe U, Sadowski J, Lipiecki J . Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012; 14(8):931-8. PMC: 3403476. DOI: 10.1093/eurjhf/hfs076. View

17.

Mihaljevic T, Gillinov A, Sabik 3rd J . Functional ischemic mitral regurgitation: myocardial viability as a predictor of postoperative outcome after isolated coronary artery bypass grafting. Circulation. 2009; 120(15):1459-61. DOI: 10.1161/CIRCULATIONAHA.109.893347. View

18.

Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon M, Trillo-Nouche R . Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015; 101(17):1395-405. DOI: 10.1136/heartjnl-2014-307120. View

19.

Armeni P, Boscolo P, Tarricone R, Capodanno D, Maggioni A, Grasso C . Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation. Int J Cardiol. 2016; 209:153-60. DOI: 10.1016/j.ijcard.2016.01.212. View

20.

Selle A, Figulla H, Ferrari M, Rademacher W, Goebel B, Hamadanchi A . Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion. Clin Res Cardiol. 2014; 103(11):902-11. DOI: 10.1007/s00392-014-0728-9. View